Delivering unique monoclonal antibodies of extreme specificity
SYnAbs' mission is to generate innovative antibodies against poor immunogenic compounds and complex antigens.
Either as a custom service,
or as a catalog product,
you can benefit
from SYnAbs technologies
to get access to
unique monoclonal antibodies.
In SYnAbs they trust
The benefits of SYnAbs technologies?
- Extreme specificity monoclonal antibodies
- Higher affinity monoclonal antibodies
- Excellent results for small, difficult and poor immunogenic antigens
- Additional epitope recognition
- High and stable producer clones
- Access to multiple immune repertoires
- Raising antibodies against difficult to express antigens
- Generating antibodies against conformation sensitive targets
SYnAbs 2019 agenda
February 1st
Feb 4th - Feb 5th
Feb 21st - Feb 22nd
March 11th - March 13th
April 2nd - April 5th
May 9th
May 21st - May 23rd
June 18th - June 19th
Aug 3rd - Aug 8th
Sep 10th - Sep 11th
Sep 10th - Sep 12th
Oct 15th - Oct 17th
Nov 11th - Nov 16th
Nov 12th - Nov 16th
Dec 10th - Dec 11th
Antwerpen, Belgium, BACR
Toulouse, France, Buzz4Bio mAb production
Leuven, Belgium, Life-on-chip
Alpach, Austria, The Alpach Workwhop
Vienna, Austria, BioProcess International
Ghent, Belgium, Knowledge for Growth
Hannover, Germany, Labvolution/Biotechnica
Oxford, United Kingdom, Pivotal Scientific
Anaheim, USA, AACC
Leuven, Belgium, Cellular heterogeneity in CNS
Copenhagen, Denmark, Nordic Life Science Days
Bale, Switzerland, Antibody European Congress
Dusseldorf, Germany, MEDICA
Lisbon, Portugal, PEGS
Marseille, France, Biofit